NeueHealth Q4 2024 GAAP EPS $(7.41) Misses $(2.48) Estimate, Sales $232.638M Miss $251.930M Estimate

NeueHealth 2024年第四季度GAAP 每股收益 $(7.41) 不及 $(2.48) 預期，銷售額 $23263.8萬不及 $25193萬預期

Benzinga · 03/20 03:57

NeueHealth (NYSE:NEUE) reported quarterly losses of $(7.41) per share which missed the analyst consensus estimate of $(2.48) by 198.79 percent. This is a 137.92 percent decrease over earnings of $19.54 per share from the same period last year. The company reported quarterly sales of $232.638 million which missed the analyst consensus estimate of $251.930 million by 7.66 percent. This is a 20.57 percent decrease over sales of $292.871 million the same period last year.

NeueHealth (紐交所:NEUE) 報告了季度每股虧損$(7.41)，遠低於分析師共識估計的$(2.48)，差距達198.79%。相比去年同期每股收益$19.54，這一數字下降了137.92%。公司報告的季度銷售額爲$23263.8萬，低於分析師共識估計的$25193萬，差距爲7.66%。與去年同期$29287.1萬的銷售額相比，這一數字下降了20.57%。

声明：本內容僅用作提供資訊及教育之目的，不構成對任何特定投資或投資策略的推薦或認可。更多信息